Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral (Z)-Endoxifen in Premenopausal Women With Measurable Breast Density
NCT05068388Phase 2Completed
- Sponsor
- Atossa Therapeutics
- Start
- Dec 2021
- Primary completion
- Jun 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of z-endoxifen in breast density, sponsored by Atossa Therapeutics. Started Dec 2021; status: completed.
02
Drugs
z-endoxifen
03
Conditions
breast density
Beyond the preview
Go deeper on NCT05068388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05068388.